Sign in
4

Changes in Ownership

Sonoma Pharmaceuticals, Inc. Filed Acc 0001209191-10-016420

Chief Executive Officer sold 15,000 shares at $3.16 ($47,343)

  • Chief Executive Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Alimi Hojabr · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2010-03-09 Exercise or conversion : show line 1 in the form +15,000 $1.10 $16,500 1,026,250 D
2010-03-10 Sale : show line 2 in the form −15,000 $3.16 $47,343 1,011,250 D
Open-market sales · 15,000 sh · avg $3.16 · $47,343

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2010-03-09 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −15,000 $1.10 $16,500 $1.10 2010-03-20 15,000 328,070 D
Loading xslF345X03/doc4.xml…